miR-3154 promotes glioblastoma proliferation and metastasis via targeting TP53INP1

Author:

Lin Xiangdan1,Wu Qiong1,Lei Wei1,Wu Dongyang1,Sheng Jianchun1,Liang Guobiao1,Hou Guojun2,Fan Di1

Affiliation:

1. General Hospital of Northern Theater Command

2. Third Affiliated Hospital of Second Military Medical University

Abstract

Abstract Glioblastomas (GBM) are most common types of primary brain tumors and miRNAs play an important role in pathogenesis of glioblastomas. Here, we reported a new miRNA, miR-3154, which regulates glioblastoma proliferation and metastasis. miR-3154 was elevated in glioblastoma tissue and cell lines, and its elevation was associated with grade of glioblastomas. Knockdown of miR-3154 in cell lines weakened ability of proliferation and colony formation, and caused cell cycle arrested and higher percentage of apoptosis. Knockdown of miR-3154 also impaired ability of migration and invasion in glioblastoma cells. In mechanism, miR-3154 bound directly to Tumor Protein P53 Inducible Nuclear Protein 1 (TP53INP1), down-regulating TP53INP1 expression at both mRNA and protein level. Silence of TP53INP1 reversed the effect of miR-3154 knockdown on proliferation and metastasis of glioblastoma cells. These findings show that miR-3154 promotes glioblastoma proliferation and metastasis via targeting TP53INP1.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, et al: Glioblastoma. Nature reviews Disease primers 2015, 1:15017.

2. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial glioblastomas;Weller M;Lancet Oncol,2017

3. Advances in the molecular genetics of glioblastomas - implications for classification and therapy;Reifenberger G;Nat reviews Clin Oncol,2017

4. Current state of immunotherapy for glioblastoma;Lim M;Nat reviews Clin Oncol,2018

5. EANO guideline for the diagnosis and treatment of anaplastic glioblastomas and glioblastoma;Weller M;Lancet Oncol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3